phosphoserine has been researched along with Ovarian Neoplasms in 9 studies
Phosphoserine: The phosphoric acid ester of serine.
Ovarian Neoplasms: Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In human ovarian cancer samples, high tumoural noradrenaline levels were correlated with high pSrc(Y419) levels." | 1.39 | Src activation by β-adrenoreceptors is a key switch for tumour metastasis. ( Allen, JK; Armaiz-Pena, GN; Bar-Eli, M; Cole, SW; Cruz, A; De Geest, K; Deavers, MT; English, RD; Gallick, GE; Gharpure, KM; Han, LY; Jackson, DB; Lin, YG; Lopez, GE; Lopez-Berestein, G; Lutgendorf, SK; Mangala, LS; Nagaraja, AS; Nick, AM; Rodriguez-Aguayo, C; Shahzad, MM; Shazhad, MM; Soldatos, TG; Soman, KV; Sood, AK; Stone, RL; Torres-Lugo, M; Villares, GJ; Vivas-Mejia, P; Wiktorowicz, JE; Wu, Z; Young, T; Zien, A; Zigler, M, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 6 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benhadjeba, S | 1 |
| Edjekouane, L | 1 |
| Sauvé, K | 1 |
| Carmona, E | 1 |
| Tremblay, A | 1 |
| Ha, JH | 1 |
| Ward, JD | 1 |
| Varadarajalu, L | 1 |
| Kim, SG | 1 |
| Dhanasekaran, DN | 1 |
| Kashiyama, T | 1 |
| Oda, K | 1 |
| Ikeda, Y | 1 |
| Shiose, Y | 1 |
| Hirota, Y | 1 |
| Inaba, K | 1 |
| Makii, C | 1 |
| Kurikawa, R | 1 |
| Miyasaka, A | 1 |
| Koso, T | 1 |
| Fukuda, T | 1 |
| Tanikawa, M | 1 |
| Shoji, K | 1 |
| Sone, K | 1 |
| Arimoto, T | 1 |
| Wada-Hiraike, O | 1 |
| Kawana, K | 1 |
| Nakagawa, S | 1 |
| Matsuda, K | 1 |
| McCormick, F | 1 |
| Aburatani, H | 1 |
| Yano, T | 1 |
| Osuga, Y | 1 |
| Fujii, T | 1 |
| Wu, J | 1 |
| Sun, Y | 1 |
| Zhang, PY | 1 |
| Qian, M | 1 |
| Zhang, H | 1 |
| Chen, X | 2 |
| Ma, D | 1 |
| Xu, Y | 1 |
| Tang, KF | 1 |
| Wang, JX | 1 |
| Zeng, Q | 1 |
| Chen, L | 1 |
| Du, JC | 1 |
| Yan, XL | 1 |
| Yuan, HF | 1 |
| Zhai, C | 1 |
| Zhou, JN | 1 |
| Jia, YL | 1 |
| Yue, W | 1 |
| Pei, XT | 1 |
| Armaiz-Pena, GN | 1 |
| Allen, JK | 1 |
| Cruz, A | 1 |
| Stone, RL | 1 |
| Nick, AM | 1 |
| Lin, YG | 1 |
| Han, LY | 1 |
| Mangala, LS | 1 |
| Villares, GJ | 1 |
| Vivas-Mejia, P | 1 |
| Rodriguez-Aguayo, C | 1 |
| Nagaraja, AS | 1 |
| Gharpure, KM | 1 |
| Wu, Z | 1 |
| English, RD | 1 |
| Soman, KV | 1 |
| Shahzad, MM | 1 |
| Shazhad, MM | 1 |
| Zigler, M | 1 |
| Deavers, MT | 1 |
| Zien, A | 1 |
| Soldatos, TG | 1 |
| Jackson, DB | 1 |
| Wiktorowicz, JE | 1 |
| Torres-Lugo, M | 1 |
| Young, T | 1 |
| De Geest, K | 1 |
| Gallick, GE | 1 |
| Bar-Eli, M | 1 |
| Lopez-Berestein, G | 1 |
| Cole, SW | 1 |
| Lopez, GE | 1 |
| Lutgendorf, SK | 1 |
| Sood, AK | 1 |
| Wang, W | 1 |
| Takimoto, R | 1 |
| Rastinejad, F | 1 |
| El-Deiry, WS | 1 |
| Wang, XJ | 1 |
| Xu, B | 1 |
| Mullins, AB | 1 |
| Neiler, FK | 1 |
| Etzkorn, FA | 1 |
| Pospísilová, S | 1 |
| Kanková, K | 1 |
| Svitáková, M | 1 |
| Nenutil, R | 1 |
| Vojtesek, B | 1 |
9 other studies available for phosphoserine and Ovarian Neoplasms
| Article | Year |
|---|---|
Feedback control of the CXCR7/CXCL11 chemokine axis by estrogen receptor α in ovarian cancer.
Topics: Binding Sites; Cell Line, Tumor; Cell Movement; Chemokine CXCL11; Chromatin; Epithelial-Mesenchymal | 2018 |
The gep proto-oncogene Gα12 mediates LPA-stimulated activation of CREB in ovarian cancer cells.
Topics: Cell Line, Tumor; Cell Proliferation; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Extra | 2014 |
Antitumor activity and induction of TP53-dependent apoptosis toward ovarian clear cell adenocarcinoma by the dual PI3K/mTOR inhibitor DS-7423.
Topics: Adenocarcinoma, Clear Cell; Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins | 2014 |
The Fra-1-miR-134-SDS22 feedback loop amplifies ERK/JNK signaling and reduces chemosensitivity in ovarian cancer cells.
Topics: 3' Untranslated Regions; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proli | 2016 |
SPINDLIN1 promotes cancer cell proliferation through activation of WNT/TCF-4 signaling.
Topics: Aurora Kinases; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cell Cycle Proteins; Ce | 2012 |
Src activation by β-adrenoreceptors is a key switch for tumour metastasis.
Topics: Adrenergic beta-Antagonists; Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclic AM | 2013 |
Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding.
Topics: Adenocarcinoma; Animals; Ataxia Telangiectasia Mutated Proteins; Carcinoma, Non-Small-Cell Lung; Cel | 2003 |
Conformationally locked isostere of phosphoSer-cis-Pro inhibits Pin1 23-fold better than phosphoSer-trans-Pro isostere.
Topics: Biomimetic Materials; Cell Line, Tumor; Dipeptides; Drug Screening Assays, Antitumor; Enzyme Inhibit | 2004 |
New monoclonal antibodies recognizing p53 protein phosphorylated by casein kinase II at serine 392.
Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antibody Specificity; Blotting, Western; Casei | 2001 |